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The working group on tropospheric ozone of the Health Effects Institute has evaluated the need for epidemiologic studies on the health effects of
ozone (03) exposure. This paper summarizes current data and identifies possible research questions. The extent to which ozone exposure results in
chronic health effects is largely undefined and is the central issue for epidemiologic studies. Most current data focus on transient endpoints; the link
between acute changes in symptoms and/or lung function and possible chronic efects has not been established. Concepts of ozone-induced health
effects have been extended to include processes of chronic disease (e.g., markers of ongoing inflammation and repair, markers of accelerated lung
aging). Traditional epidemiologic studies performed have focused only on accelerated lung aging and are limited by a number of methodologic prob-
lems. Recent, very preliminary, studies suggest new opportunities forthe use of human lung tissue and a variety biological response markers as part
of epidemiologic studies. The identification of sensitive subpopulations with regard to ozone-induced health effects has been studied incompletely
and is important both in terms of study efficiency and mechanistic insight. Methodologic advances in the reconstruction of past ozone exposure are
seen as essential, as is the incorporation of emerging markers of biologic response to ozone into traditional epidemiologic study designs. Finally,
more data on the joint and independent contribution of other ambient air pollutants to putative ozone-induced health effects is warranted. - Environ
Health Perspect 101(Suppl 4):205-207 (1993).
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Background
An extensive body of data has been devel-
oped on the biologic, physiologic, and
health effects of ozone. Two recent com-
prehensive reviews (1,2) summarize this
information. From these reviews, it is clear
that epidemiologic studies represent only a
small part of the current knowledge base
on possible health effects ofozone and that
considerable opportunities exist for epi-
demiologic studies to fill in many of the
gaps in the current state of knowledge
about these effects.
The working group on tropospheric
ozone has addressed Health Effects
Institute's (HEI's) objectives with regard to
needed epidemiologic research through the
following steps: identification of general
research questions with regard to ozone-
induced health effects that the committee felt
most needed to beaddressed andformulation
of these research questions in terms suitable
for epidemiologic study designs. At each
stage ofthis process, consideration was given
to the theoretical andpractical advantages of
available study design alternatives and the
need to consider newdesignapproaches.
This manuscript was prepared as part of the Environ-
mental Epidemiology Planning Project of the Health
Effects Institute, September 1990-September 1992.
*Present address: 140 Earl Warren Hall, University
of California, Berkeley, School of Public Health,
Berkeley, CA 94720
The remainder of this introduction is
devoted to a briefsummary ofthe working
group discussions on the general research
needs that guided the development of the
papers that follow.
The extent to which ozone results in
chronic health effects in humans remains
largely undefined and is a central issue for
epidemiologic studies. Data from primate
exposure studies suggest that permanent or
poorly reversible changes in the distal air-
ways and proximal alveolar regions of the
lung might be important consequences of
prolonged ozone exposure (3,4). Recent
chamber studies of the acute effects of
ozone exposure on the dispersion ofinhaled
aerosol boluses support the possibility that
similar small airway alterations occur in
otherwise healthy humans (5) and could be
precursor lesions to a more chronic process.
To date, most studies ofozone-induced
health effects in humans have focused on
specific transient endpoints (e.g., symptoms,
change in lung function after acute expo-
sure, one-time assessment ofcellular and/or
biochemical markers of inflammation and
repair). Moreover, the link between current
measures ofacute symptomatic and/or func-
tional responses to ozone (6,7) and the
occurrence ofchronic effects has not been
established inhumans, norhas it been estab-
lished that the mechanisms that underlie
acute effects [e.g., airways hyperreactivity
(8), reflex neural alterations of measured
vital capacity (9), inflammatory changes
(10)] are the same as those that underlie
chronic effects (e.g., loss of lung elastic
recoil, deposition ofexcess collagen).
Analogous to studies ofthe natural his-
tory ofthe effects ofcigarette smoke on lung
function and the subsequent occurrence of
chronic pulmonary disease (11), concepts of
ozone-induced health effects have to be
extended beyond the evaluation ofspecific
endpoints to indude processes indicative of
chronic disease (e.g., markers of ongoing
inflammation and repair, biochemical and/or
physiological markers of accelerated lung
aging, etc.). To date, traditional, popula-
tion-based epidemiologic studies that have
tried to address process (e.g., accelerated
dedine inlungfunction) have been restricted
to the evaluation of a limited range oflung
function measures. They also have been
handicapped by a number ofproblems: a)
large losses to follow-up (12,13), which on
the surface do not appear to have affected
validity; b) inadequate characterization of
individual and group exposure to ozone
prior to study onset; c) difficulties in obtain-
ing detailed data on concurrent ozone expo-
sureforlarge numbers ofsubjects; d) lackof
data on modiying and/or confounding fac-
tors; and e) the relatively short duration of
follow-up (12,13) or the purely cross-sec-
tional nature oftheir evaluation (14). These
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studies have derived their epidemiologic
appeal from a perceived need to have study
samples from whom generalizations can be
made to some population at large. These
studies were considered to be of continued
relevance for comprehensive policy analysis
into the health and economic impact of
exposure to ozone, but theywere thought to
be ofless importance in terms ofefficiency
for studies aimed at the identification of
acute and chronic health effects and chronic
alterations ofbiological processes (e.g., pre-
mature aging of the lung). Epidemiologic
studies in targeted populations (e.g., persons
moving between localities with different
ozone exposure characteristics, asthmatics)
were considered as alternatives to provide
valid data with greater efficiency for the
determination of the extent to which acute
and chronic health effects occur and for the
characterization ofsuch effects.
To address the issue of pathophysio-
logic process, innovative study designs that
use new sources ofdata on the response of
humans to ozone were considered in detail.
Despite a number ofsignificant limitations,
the working group felt that the recent
autopsy study of Sherwin and Richters
(15), which reported an excess of severe
respiratory bronchiolitis in the lungs of
young accident victims who lived in Los
Angeles, suggested important new opportu-
nities for epidemiologic studies of chronic
ozone-induced health effects. The devel-
opment of well-designed autopsy studies
and living population studies ofinflamma-
tory markers might provide a means to
identify early pathologic changes that, by
analogy to data for cigarette smoke
(16,17), represent precursor lesions for
more serious chronic effects and/or relate
to acute and subacute functional changes
in the lung. Study designs that utilize indi-
viduals who move, either temporarily or
permanently, to and from areas with major
differences in ambient ozone concentra-
tions were seen as creative means to test
hypotheses about functional changes in the
lung and health effects in general (18).
The identification ofsensitive subpopula-
tions with regard to ozone-induced health
effects (especially chronic effects) was consid-
ered to be important both for study design
efficiency and for mechanistic (biologic)
insight. Asthmatics, in particular, were sin-
gled out for consideration because of their
increased reactivity to a variety of environ-
mental stimuli. Thisapproach wassupported
by population-based studies that demon-
strated an association between acute asthma
and other respiratory morbidity (emergency
room visits) and other air pollutants (19).
The failure ofcontrolled exposure studies to
identify, unequivocally, asthmatics as a sen-
sitive subpopulation was not seen as limit-
ing in this context, since it may have been
the result of a) inadequate exposures used
in the controlled exposure studies that have
been conducted to date (20), b) the inclu-
sion of only milder asthmatics, c) the
exdusion of asthmatics with acute respira-
tory illness or its exacerbation, and d) fail-
ure to simulate the complex mix of air
pollutants to which such individuals may
be exposed (13). Epidemiologic studies, in
conjunction with additional controlled
exposure studies (20,21), were considered
essential to address the above problems and
to identify more clearly other sensitive sub-
groups and the factors that define sensitiv-
ity to ozone. A recent study that indicates
that ozone exposure may enhance lung air-
way responsiveness to aeroallergens (22)
adds further impetus to this focus.
Standardized questionnaire assessment
and measurement of forced expiratory vol-
umes and flows have been the primary out-
comes that have been used in controlled
exposure and epidemiologic studies to iden-
tify individuals who respond to ozone expo-
sure (e.g., report of a symptom(s) or a
change in level ofvolume or flow after expo-
sure). On a more limited basis, markers of
lung inflammation, as assessed through
analysis of the fluid and cellular phases of
bronchoalveolar lavage, have been employed
to expand the concept ofresponse to ozone
(23). Given the importance attached to the
ozone-sensitive population in the working
group's formulations, it was imperative that
the studies of ozone-induced health effects
indude more proximate markers ofbiologic
effect (damage, repair, etc.) and measures of
pulmonary function that may be more sensi-
tive markers ofeffect or mayreflect a broader
range of functional alteration [e.g., changes
in thedistribution ofinhaled aerosols (5)].
Although not unique to epidemiologic
studies ofozone-induced acute and chronic
health effects, methodologic advances were
seen as necessary for the retrospective recon-
struction ofpast ozone exposure status (e.g.,
identification ofsuitable, long-term, air pol-
lutant monitoring databases, development
of indices of relevant past exposure, time-
activity indices, etc.). It was felt that the
need for valid and reproducible methods
that assess retrospective and concurrent
exposure that are suitable for epidemiologic
studies is ofsufficient importance to merit
independent study. Moreover, the suitabil-
ity of existing (24,25) and evolving (25)
models to estimate individual ozone expo-
sure in epidemiologic studies was considered
to be in need of further definition, as were
models that have utility for a wide variety of
epidemiologic studydesigns.
In this context, ozone exposure indices
need to account for the independent and
joint effects of other air pollutants. The
relationship ofthe distribution ofozone to
other pollutants (e.g., acid aerosols) was
seen as playing an important role in the
selection ofstudy locations and the integra-
tion ofresults from studies from a number
ofdiffering geographical locations.
While issues of statistical analysis were
not the principal purview of the working
group, statistical issues figured prominently
in the discussions. In particular, the work-
ing group felt that study designs of ozone-
related health effects need to be able to
incorporate new approaches to the analysis
ofwithin- and between-subject variability in
response to given ozone exposures.
Moreover, this variability, particularly
within individuals, was considered an
important endpoint for study in its own
right, especiallygiven the evolutionaryadap-
tation to ozone that has been observed in
some controlled exposure studies (26,27).
Research Questions for the
Study of Ozone-induced
Health Effects
The working group established a series of
discrete questions to which the members
have addressed their presentations. Within
the framework of a particular question, a
brief background is presented that is
intended to provide a context for the discus-
sion rather than a comprehensive summary
ofavailable research data. Where appropri-
ate, issues of exposure assessment and the
specification of a range ofstudy designs are
discussed or very specific designs are sug-
gested (28,29). In these latter cases, the
designs that are presented are done so
because the workinggroup felt that the illus-
tration ofa specific design best captured the
research needs in question. Finally, while
several ofthe papers discuss issues ofanalysis,
the overall views ofthe working group have
beensynthesized in asingle, morestatistically
orientedpresentation (30).
The following questions reflect the syn-
thesisoftheworkinggroup's deliberation and
theguideline fortheartides in thisvolume.
ChronicEffects and Processes
Whatstudy (studies) is (are) required to deter-
mine whether ozone causes chronic health
effects? How can population studies be uti-
lized to determine ifrespiratory bronchiolitis
is caused by ozone? Is premature aging ofthe
lung related to this process (as a consequence
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ofozone exposure)? What is (are) the optimal
methodologic approach(es) to determine if
ozoneleads topremature agingofthelung?
How can the direct analysis oflung tis-
sue be used to evaluate the chronic effects of
ozone exposure? What is (are) the optimal
method(s) for retrospective exposure assess-
ment that would be needed for such tissue
analyses? What are the optimal methods for
subject and tissue selection, analyses, and
data management that would ensure valid
comparisons overwide geographic areas?
Acute Effects
What is the full range ofacute outcomes due
to ozone exposure, and which of these out-
comes relate to specific chronic disease out-
comes and chronic changes in physiological
processes?
Sensitive/Susceptible Populations
with Regard to Ozone Exposure
Are there sensitive subpopulations in rela-
tion to ozone exposure and how can they
be identified? What laboratory-based end-
points are almost ready for use in epidemi-
ologic studies? What new laboratory-based
endpoints need to be developed for the
identification of susceptible individuals in
epidemiologic studies? What is the rela-
tionship of the epidemiology of asthma to
ozone exposure?
Analytical Issues
What are the important (and new) issues
required in the design and/or the analysis
of epidemiologic studies of the health
effects ofozone? What study designs most
appropriately reflect the need to study bio-
logical variability in response to acute and
chronic exposure to ozone?
The paper ofthe working group address
each ofthese issues separately. A conclud-
ing paper (e.g.) will pull together common
threads that appear throughout each ofthe
sections to highlight the central research
issues that will form the basis for specific
recommendations. eg
REFERENCES
1. Lippmann M. Health effects ofozone: a critical review. Journal of
theAir Pollution Control Association 39:672-695 (1989).
2. Lippmann M. Effects of ozone on respiratory function and struc-
ture. Ann Rev Public Health 10:49-67 (1989).
3. Moffatt RK, Hyde DM, Plopper CG, Tyler WS, Putney LF.
Ozone-induced adaptive and reactive cellular changes in respiratory
bronchioles ofbonnet monkeys. Exp Lung Res 12:57-68 (1987).
4. Hyde DM, Plopper CG, Harkema JR, St. George JA, Tyler WA,
Dungworth DL. Ozone-induced structural changes in monkey res-
piratory system. In: Atmospheric ozone research and its policy
implications (Schneider T, Lee SD, Wolters GJR, Grant LD, eds).
Amsterdam: Elsevier Science Publishers, 1989; 398-400.
5. Keefe JJ, Bennet WD, Dewitt P, Seal E, Strong AA, Gerrity TR.
The effect of ozone exposure on the dispersion of inhaled aerosol
boluses in healthy human subjects. Am Rev Respir Dis 144:23-30
(1991).
6. Ostro BD, Lipsett MJ. Predicting respiratory morbidity from pul-
monary function tests: a reanalysis ofozone chamber studies. Journal
oftheAir Pollution Control Association 39:1313-1318 (1989).
7. Gong H, Simmons MS, McManus MS, Tashkin DP, Clark VA,
Detels R, Clark JJ. Relationship between responses to chronic oxi-
dant and acute ozone exposures in residents ofLos Angeles County.
Am Rev Respir Dis 141(4/2):A70 (1990).
8. Aris R, Christian D, Sheppard D, Balmes JR. The effects of
sequential exposure to acidic fog and ozone on pulmonary function
in exercising subjects. Am Rev Respir Dis 143:85-91 (1991).
9. Hazucha MJ, Bates DV, Bromberg PA. Mechanism of action of
ozone on the human lung. J Appl Physiol 67:1535-1541 (1989).
10. Devlin RB, McDonnell WF, Mann R, Becker S, House BE,
Schreinemachers D, Koren HS. Exposure of humans to ambient
levels of ozone for 6.6 hours causes cellular and biochemical
changes in the lung. AmJ Respir Cell Mol Biol 4:72-81 (1991).
11. U.S. Department of Health and Human Services, Office on
Smoking and Health. The health consequences of smoking-
chronic obstructive lung disease: a report ofthe Surgeon General.
DHHS Publication No (CDC) 84-50205. Washington, DC: U.S.
Government Printing Office, 1984.
12. Detels R, Tashkin DP, SayreJW, Rokaw SN, Coulson AH, Massey
FJ, Wegman DH. The UCLA population studies of chronic
obstructive respiratory disease. 9. Lung function changes associ-
ated with chronic exposure to photochemical oxidants; a cohort
study among never-smokers. Chest 92:594-603 (1987).
13. Detels R, Tashkin DP, Sayre JW, Rokaw SN, Massey FJ, Coulson
AH, Wegman DH. The UCLA population studies ofCORD: X.
Cohort study of changes in respiratory function associated with-
chronic exposure to SOx, NOx, and hydrocarbons. Am J Public
Health 81:350-359 (1991).
14. Kilburn KH, Warshaw R, Thornton JC. Pulmonary functional
impairment and symptoms in women in the Los Angeles harbor
area. AmJ Med 79:23-28 (1985).
15. Sherwin RP, Richters V. Centriacinar region (CAR) disease in the
lungs of young adults-a preliminary report. In: Tropospheric
ozone and the environment: papers from an international confer-
ence (Transaction 19). Air and Waste Management Assoc, 1991.
16. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in
the peripheral airways ofyoung cigarette smokers. N Engl J Med
291:755-758 (1974).
17. Cosio MG, Hale KA, Niewoehner DE. Morphologic and morpho-
metric effects ofprolonged cigarette smoking on the small airways.
Am Rev Respir Dis 122:265-271 (1980).
18. Kinney PL, Skordinski M, He DK, Gorczynski J, Hayes C,
Lippmann M. Subchronic change in FEV1 associated with ambi-
ent ozone exposures. Am Rev Respir Dis 143(4/2):A96 (1991).
19. Bates DV, Sizto R. Air pollution and hospital admissions in south-
ern Ontario: the acid summer haze effect. Environ Res
43:317-331 (1987).
20. Balmes JR. The role of ozone exposure in the epidemiology of
asthma. Environ Health Perspect 101 (Suppl 4) 219-224 (1993).
21. Ostro, BD. Examining acute health outcomes due to ozone expo-
sure and their subsequent relationship to chronic disease outcomes.
Environ Health Perspect 101 (Suppl 4) 213-216 (1993).
22. Molfino NA, Wright SC, Datz I, Tarlo S, Silverman R, McClean
PA, Szalai JP, Raizenne M, Slutsky AS, Zamel N. Effect of low
concentrations ofozone on inhaled allergen responses in asthmatic
subjects. Lancet 338:199-203 (1991).
23. Doren HS, Devlin RB, Graham DE, Mann R, McGee MP,
Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnell
WF, Bromberg PA. Ozone-induced inflammation in the lower air-
ways ofhuman subjects. Am Rev Respir Dis 139:407-415 (1989).
24. Hayes SR. Estimating the effect ofbeing indoors on total personal
exposure to outdoor air pollution. Journal of the Air Pollution
Control Association 39:1453-1461 (1989).
25. Johnson TR, Paul RA, CapelJE, McCurdy T. Estimation ofozone
exposure in Houston using a probabilistic version of NEM.
Presented at the 83rd Annual Meeting of the Air and Waste
Management Association, Pittsburgh, PA, 1990.
26. Horvath SM, Gliner JA, Folinsbee LJ. Adaptation to ozone: dura-
tion ofeffect. Am Rev Respir Dis 123:496-499 (1981).
27. Linn WS, Avol EL, Anderson KR, Shamoo DA, Peng RC,
Hackney JD. Respiratory responses of healthy volunteers in pro-
longed repeated exposures to ozone and sulfuric acid. Am Rev
Respir Dis 143(4/2):A97 (1991).
28. Bates D. Detection ofchronic respiratory bronchiolitis in an oxi-
dant-exposed populations: analogy to tobacco smoke exposure.
Environ Health Perspect 101 (Suppl 4) 217-218 (1993).
29. Lippmann M. Use ofhuman lung tissue for studies of structural
changes associated with chronic ozone exposure: opportunities and crit-
ical issues. Environ Health Perspect 101 (SuppI4) 209-212 (1993).
30. MunozA. Design and analysis ofstudies ofthe health effects ofozone.
Environ Health Perspect 101 (Suppl 4) 231-235 (1993).
Environmental Health Perspectives Supplements 207
Volume 101, Supplement 4, December 1993